Fuck Alzheimer's

A large scale global study from ADI and the London School of Economics and Political Science examines the attitudes of people toward dementia. Read & Research Alzheimer’s More

The relationship between alcohol consumption and dementia risk in older adults is proving difficult to unpick. A recent study takes a fresh look. Read & Research Alzheimer’s More

The 2018 National Institute on Aging and the Alzheimer’s Association (NIA-AA) research framework recently redefined Alzheimer’s disease (AD) as a biological construct, based on in vivo biomarkers reflecting key neuropathologic features. Combinations of normal/abnormal levels of three biomarker categories, based on single thresholds, form the AD signature profile that defines the Read & Research Alzheimer’s More

Neuron damage and death in Alzheimer’s and other neurodegenerative diseases may be preventable by targeting a shared cause of inflammation. Read & Research Alzheimer’s More

New evidence suggests that managing blood pressure may help slow down the progression of cognitive decline in people with Alzheimer’s disease. Read & Research Alzheimer’s More

The prevalence, mortality, and healthcare impact of Alaska Native and American Indian (ANAI) people with Alzheimer’s disease and related dementias (ADRD) are unknown. Read & Research Alzheimer’s More

A new study suggests that people with Lewy body dementia and Alzheimer’s have distinct walking patterns that may match cognitive and disease changes. Read & Research Alzheimer’s More

Questions remain about whether apolipoprotein E (APOE)-ε4 effects on cognitive decline are similar in men and women and how APOE-ε4 and age interact to influence decline in different cognitive domains. Read & Research Alzheimer’s More

The Multidomain Alzheimer Preventive Trial (MAPT) assessed the efficacy of omega-3 fatty acid supplementation, a multidomain intervention (MI), or a combination of both on cognition. Impact according to cerebral amyloid status was evaluated by PET scan. Read & Research Alzheimer’s More

• Julie Gregory posted on September 24, 2019
  Your MAPT link doesn't work :-) Please update.

A clinical trial has found that an innovative electromagnetic therapy device significantly reduced memory loss in seven out of the eight participants. Read & Research Alzheimer’s More

We aimed to refine the hypothesis that dementia has a unique signature of gait impairment reflective of underlying pathology by considering two dementia subtypes, Alzheimer’s disease (AD) and Lewy body disease (LBD), and exploring the role of cognition in disease-specific gait impairments. Read & Research Alzheimer’s More

A new proof-of-concept study finds that people with Alzheimer’s biomarkers in the brain who exercise frequently experience slower deterioration. Read & Research Alzheimer’s More

Caring for someone with Alzheimer’s disease can be both challenging and rewarding. Learn about tips to make it easier, as well as when to seek professional help. Read & Research Alzheimer’s More

A recent study concludes that wearing hearing aids is associated with later onset of dementia and a reduced risk of anxiety, depression, and falls. Read & Research Alzheimer’s More

New research finds a ‘significant’ association between a history of migraine and various forms of dementia, and Alzheimer’s disease in particular. Read & Research Alzheimer’s More

Environmental factors are poorly understood in the etiology of Alzheimer’s disease (AD) and related dementias. The importance of environmental factors in gene environment interactions (GxE) is suggested by wide individual differences in cognitive loss, even for carriers of AD-risk genetic variants. Read & Research Alzheimer’s More

Poor gait has recently emerged as a potential prodromal feature of cognitive decline and dementia. We assessed to what extent various aspects of poor gait are independently associated with cognitive decline and incident dementia. Read & Research Alzheimer’s More

Individuals with homozygosity for the apolipoprotein E (APOE) ε4 allele are in the highest risk category for late-onset Alzheimer’s disease (LOAD). However, some individuals in this category do not develop LOAD beyond the age of 75 years, despite being at elevated genetic risk. These “resilient” individuals may carry protective genetic factors. Read & Research Alzheimer’s More

Large longitudinal biomarkers database focusing on middle age is needed for Alzheimer’s disease (AD) prevention. Read & Research Alzheimer’s More

Raspberry ketones are the compounds that give raspberries their smell. Some people believe that they provide health benefits. Learn about the possible uses and side effects of raspberry ketones here. Read & Research Alzheimer’s More

It is unclear the degree to which tau pathology in the medial temporal lobe (MTL) measured by 18F-flortaucipir positron emission tomography relates to MTL subregional atrophy and whether this relationship differs between amyloid-β–positive and amyloid-β–negative individuals. Read & Research Alzheimer’s More

The low mild cognitive impairment (MCI) to cognitively normal (CN) reversion rate in the Alzheimer’s Disease Neuroimaging Initiative (2-3%) suggests the need to examine reversion by other means. We applied comprehensive neuropsychological criteria (NP criteria) to determine the resulting MCI to CN reversion rate. Read & Research Alzheimer’s More

Plasma proteins have been widely studied as candidate biomarkers to predict brain amyloid deposition to increase recruitment efficiency in secondary prevention clinical trials for Alzheimer’s disease. Most such biomarker studies are targeted to specific proteins or are biased toward high abundant proteins. Read & Research Alzheimer’s More

There is insufficient understanding of diagnosis of etiologic dementia subtypes and contact with specialized dementia care among older Americans. Read & Research Alzheimer’s More